Gene Therapy Cuts Bad Cholesterol 62% in New Trial

A one-time gene-editing treatment lowered dangerous cholesterol levels by 62% in early human trials, offering hope for millions who struggle with heart disease prevention.

The therapy produced no serious side effects, marking a major safety milestone.